Forecast the future of oncology across 40+ indications

DRG Disease Landscape & Forecast

Clarivate’s Disease Landscape & Forecast reports provide expert-driven, patient-based insights to power confident planning across the oncology pipeline.

Covering 40+ tumor types, each report delivers in-depth forecasting, clinical development analysis, and strategic market context – all tailored to pharma, biotech, and investment needs.

Request more information north_east

Request more information

What’s included in the reports?

  • Forecasts through 2033
    Patient-based 10-year market outlooks by indication.
  • Indication-specific strategy insights
    Explore treatment trends, access, reimbursement, and market dynamics.
  • Late-phase pipeline intelligence
    Track Phase IIb/III assets and timelines to stay ahead of competitors.
  • Expert commentary
    Interpret data with clarity from our oncology analysts, therapy area experts, and epidemiologists.

Preview some of the oncology reports below

Sample report
Breast cancer

north_east View sample report
Sample report
Non-small-cell-lung cancer

north_east View sample report
Sample report
Prostate cancer

north_east View sample report

Covering 40+ oncology indications including:

Breast cancer, colorectal cancer, prostate cancer – and many more

Learn more 3p

Tailored to your needs

Whether you need insight into a single tumor type or want a bundled view to guide portfolio planning, we’ve got you covered.

Connect with our team to explore the right options for your pipeline and commercial goals.

Connect nownorth_east

Request more information